HUMA · Humacyte, Inc. · Investor Relations
$0.50
-0.02 (-4.12%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company will not have sufficient liquidity to fund its operations beyond one year from the issuance of these condensed consolidated financial statements if the Company is unable to generate sufficient cash flows from commercial sales on a timely basis and/or obtain additional capital. These factors raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$154.82M
Shares
277.80M
Volume · Oct 5
6.45M
Avg daily vol (3M)
6.46M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-12 | Humacyte Second Quarter 2026 Financial Results and Corporate Update | Earnings call |
| 2026-05-13 | Humacyte First Quarter 2026 Financial Results and Corporate Update | Results publication |
| 2026-04-28 | Humacyte Virtual KOL Event to Discuss ATEV for Arteriovenous (AV) Access for Hemodialysis Patients | Event |
| 2026-03-27 | Humacyte Fourth Quarter and Full Year 2025 Financial Results and Corporate Update | Results publication |
Source: https://humacyte.com/investors/